Publications

Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.

Zhu D. et al, (2026), American journal of kidney diseases : the official journal of the National Kidney Foundation, 87, 564 - 568

Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.

Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists' (CTT) Collaboration ., (2026), Lancet (London, England)

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.

Nielsen AB. et al, (2026), JAMA internal medicine

Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial.

Espersen C. et al, (2026), The Journal of infectious diseases, 233, e89 - e98

A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.

Johansen ND. et al, (2026), American heart journal, 291, 186 - 198

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2026), The Lancet. Infectious diseases, 26, 34 - 45

Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial.

Bernholm KF. et al, (2026), European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 Trial.

Espersen C. et al, (2025), Journal of the American College of Cardiology, 86, 2651 - 2655

A Bayesian re-analysis of the DANFLU-1 trial.

Modin D. et al, (2025), Human vaccines & immunotherapeutics, 21

High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis.

Bartholdy KV. et al, (2025), Journal of the American College of Cardiology, 86, 2636 - 2647

Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis.

Estrella MM. et al, (2025), JAMA, 334, 1915 - 1926

Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.

Herrington WG. et al, (2025), The lancet. Diabetes & endocrinology, 13, 1003 - 1014

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.

Johansen ND. et al, (2025), The New England journal of medicine, 393, 2291 - 2302

Recommended methodologies for clinical investigations of high-risk medical devices-Conclusions from the European Union CORE-MD Project.

Fraser AG. et al, (2025), The Lancet regional health. Europe, 58

High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.

Johansen ND. et al, (2025), JAMA cardiology, 10, 1186 - 1194

Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial.

Duus LS. et al, (2025), Respiratory investigation, 63, 1309 - 1315

Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.

Malijan GB. et al, (2025), Kidney international reports, 10, 4090 - 4093

High-Dose Versus Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial.

Skaarup KG. et al, (2025), Circulation. Heart failure, 18

High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1.

Langhoff AF. et al, (2025), Journal of clinical hypertension (Greenwich, Conn.), 27

High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.

Pareek M. et al, (2025), European heart journal, 46, 4282 - 4290

Cookies on this website

Search results (315)